-
Puts Purchased on Warner Chilcott (WCRX)
Friday, February 11, 2011 - 11:51am | 121Shares of Warner Chilcott (NASDAQ: WCRX) are higher on the session by 2.10%, currently trading at $23.84. The stock has been moving largely higher over the past three months and is currently consolidating around the 50-day and 200-day moving averages. Options traders are buying puts on the name...
-
Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
Friday, February 11, 2011 - 10:15am | 83Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5...
-
Cyanotech Reports Financial Results for Q3
Friday, February 11, 2011 - 9:08am | 51Cyanotech Corporation (NASDAQ: CYAN), reported Q3 revenues of $3,919,000 compared to revenues of $3,982,000. Gross profit was $1,232,000, with gross profit margin of 31%, compared to gross profit of $1,750,000 and gross profit margin of 44%. Net income was $10,000, or $0.00 per diluted share,...
-
Deutsche Bank Maintains Buy Rating, $28 PT On AUXL
Friday, February 11, 2011 - 8:52am | 165Deutsche Bank is tweaking its Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) 2011 revenue estimate from $268M to $269M but lowering its 2011 EPS estimate from $(0.56) to $(0.83), primarily on higher R&D and lower gross margins. “We are also modestly lowering our 2012-14 revenue and EPS estimates...
-
A Peek Into The Market Before The Trading Starts
Friday, February 11, 2011 - 8:48am | 592Pre-open movers US stock futures are lower this morning. Shares of Nokia Corp (NYSE: NOK) dropped in pre-market trading as the company unveiled partnership with Microsoft Corp (NASDAQ: MSFT). Futures for the Dow Jones Industrial Average dropped 39 points to 12,155, while those for the S&P 500...
-
Eli Lilly Announces Senior Leadership Changes
Friday, February 11, 2011 - 8:15am | 80Eli Lilly and Company (NYSE: LLY) today announced that Sue Mahony, currently senior vice president of human resources and diversity, has been named senior vice president and president of Lilly Oncology. Being promoted into Mahony's former role is Steve Fry, currently vice president of human...
-
Optimer Pharmaceuticals Announces Public Offering; No Amount Given
Thursday, February 10, 2011 - 5:44pm | 79Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering are to be sold by Optimer. The offering is subject to market conditions, and there can be no assurance as...
-
Hi-Tech Pharmacal Receives Final Approval for Levofloxacin Ophthalmic Solution
Thursday, February 10, 2011 - 3:12pm | 81Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin® ophthalmic solution, which had...
-
Lannett Reports Q2 EPS of $0.09 vs. $0.02
Thursday, February 10, 2011 - 12:01pm | 133Lannett Company, Inc. (NYSE: LCI) today reported financial results for the fiscal 2011 second quarter and first six months ended December 31, 2010. For the second quarter of fiscal 2011, net sales rose to $30.0 million, compared with $28.7 million for the second quarter of fiscal 2010. Gross...
-
Jefferies Maintains Buy on Amarin Corp. (AMRN)
Thursday, February 10, 2011 - 9:33am | 88Jefferies is out with its report today on Amarin Corp. (NASDAQ: AMRN), maintaining Buy. In a note to clients, Jefferies writes, "We believe AMR101 offers robust efficacy for hyperlipidemia, lowering triglycerides without raising cholesterol like Lovaza. With a cleaner profile and potentially a...
-
Perrigo Announces Settlement of Rogaine Foam Patent Litigation
Thursday, February 10, 2011 - 9:32am | 91Perrigo Company (Nasdaq: PRGO) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Minoxidil foam brought by Stiefel Research Australia Pty. Ltd., a GSK Company. Under the terms of the settlement, Perrigo can launch in the U. S., a generic version of Men's Rogaine®...
-
Benzinga's Top Pre-Market NASDAQ Gainers (WFMI, PGNX, SQNM, XNPT)
Thursday, February 10, 2011 - 9:26am | 139Whole Foods Market Inc (NASDAQ: WFMI) rose 9.02% to $58.60 in the pre-market session. WFMI raised its 2011 projections for profit and sales. Progenics Pharmaceuticals Inc (NASDAQ: PGNX) added 8.20% to $6.20 in the pre-market session. PGNX had $58.39 million in total cash and no debt for the...
-
Auxilium Pharmaceuticals Reports Mixed Results (AUXL)
Thursday, February 10, 2011 - 8:22am | 197Malvern, Pennsylvania-based biopharmaceutical company 3Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) on Thursday morning released financial results that failed to meet Wall Street earnings expectations, while beating revenue estimates. Auxilium Pharmaceuticals, Inc reported that its 4th quarter net...
-
Mad Money Lightning Round: Cramer Likes United Parcel Service (AMRN, UPS, WFMI, FDX, NEE)
Thursday, February 10, 2011 - 4:52am | 166On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Amarin (NASDAQ: AMRN) is a “speculative stock.” He added, “I think it's a don't-buy situation." He said that United Parcel Service (NYSE: UPS) is “going still higher. This is a great American company and they're going a fabulous...
-
Morgan Stanley Lowers TEVA Estimates
Wednesday, February 9, 2011 - 11:10am | 97Morgan Stanley is lowering its 2011e revenue on Teva Pharmaceutical Industries (NASDAQ: TEVA) from $19.1B to $18.7B (vs. mgmt's $18.5-$19.5B) and 2011e EPS from $5.29 to $5.05 (midpoint of mgmt's $4.90-$5.20). “We also lower our 2012e EPS from $6.04 to $5.78 to be more in-line with mgmt's $5.30-$5....